We are live on ! Find out more
SGMT icon

Sagimet Biosciences
SGMT

70 hedge funds and large institutions have $44.9M invested in Sagimet Biosciences in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

24% more call options, than puts

Call options by funds: $539K | Put options by funds: $436K

6% more funds holding

Funds holding: 66 → 70 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 18

12.14% less ownership

Funds ownership: 57.04% → 44.9% (-12%)

43% less capital invested

Capital invested by funds: $78.8M → $44.9M (-$33.8M)

Holders
70
Holders Change
+4
Holders Change %
+6.06%
% of All Funds
0.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
16
Reduced
18
Closed
13
Calls
$539K
Puts
$436K
Net Calls
+$103K
Net Calls Change
+$1.09M

Top Buyers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
+$1.45M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.02M
3
UBS Group
UBS Group
Switzerland
+$609K
4
FIA
FNY Investment Advisers
New York
+$213K
5
DP
Diadema Partners
New Jersey
+$193K

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$9M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.94M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.35M
4
Millennium Management
Millennium Management
New York
-$2.23M
5
Marshall Wace
Marshall Wace
United Kingdom
-$761K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
51
Boothbay Fund Management
New York
$40.8K – – –
IC
52
Ikarian Capital
Texas
$39.1K – – –
PFCS
53
Pale Fire Capital SE
Czech Republic
$35.8K -$30.7K -7,321 -40%
XT
54
XTX Topco
Cayman Islands
$35.2K +$45.3K +10,811 New
PAP
55
Persistent Asset Partners
Hong Kong
$34.5K +$44.4K +10,597 New
JWM
56
Jacksonville Wealth Management
Florida
$32.6K – – –
MAM
57
Meeder Asset Management
Ohio
$18.2K – – –
Bank of America
58
Bank of America
North Carolina
$17.8K -$40.2K -9,573 -64%
NFSG
59
Newbridge Financial Services Group
Florida
$4.89K – – –
CIAM
60
Caitong International Asset Management
Hong Kong
$3.89K +$2.19K +523 +78%
RAM
61
Riggs Asset Management
Pennsylvania
$3.34K – – –
IA
62
IFP Advisors
Florida
$3.26K +$4.2K +1,000 New
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$2K +$2.1K +500 New
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$942 -$7.08K -1,688 -85%
Barclays
65
Barclays
United Kingdom
$460 -$298 -71 -33%
SS
66
SBI Securities
Japan
$398 +$348 +83 +213%
JP Morgan Chase
67
JP Morgan Chase
New York
$319 -$201K -47,966 -100%
Fidelity Investments
68
Fidelity Investments
Massachusetts
$156 – – –
HCM
69
Hollencrest Capital Management
California
$49 +$63 +15 New
Osaic Holdings
70
Osaic Holdings
Arizona
$32 +$42 +10 New
NMC
71
NEA Management Company
Maryland
– -$9M -2,000,275 Closed
6CM
72
683 Capital Management
New York
– -$622K -138,263 Closed
Citigroup
73
Citigroup
New York
– -$500K -111,208 Closed
Squarepoint
74
Squarepoint
New York
– -$227K -50,484 Closed
SSA
75
Schonfeld Strategic Advisors
New York
– -$178K -39,452 Closed
1 2
3
4

SGMT Hedge Fund Activity: Q1 2025 in Review

70 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Sagimet Biosciences (SGMT) for Q1 2025, worth a combined $44.9M — down 43% from $78.8M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SGMT positions and 13 closed out — a net gain of 5 holders — while 16 added to existing stakes and 18 trimmed.

The largest buyer was Raymond James Financial, opening a new position worth an estimated $1.45M. The largest seller was NEA Management Company, exiting entirely with an estimated $9M sold.

  • 70 institutional investors held Sagimet Biosciences (SGMT) as of Q1 2025, up from 66 in Q4 2024.
  • Funds reported $44.9M of Sagimet Biosciences stock for Q1 2025, down 43% quarter-over-quarter.
  • 18 funds opened new Sagimet Biosciences positions in Q1 2025 and 13 closed out, a net change of +5 holders.
  • The largest Sagimet Biosciences buyer in Q1 2025 was Raymond James Financial, an estimated $1.45M added.
  • The largest Sagimet Biosciences seller in Q1 2025 was NEA Management Company, an estimated $9M sold.

Based on aggregated 13F filings for Q1 2025.